Physician profile
Sheila Pieczonka
NPI 1720071780
$970.10
in general payments reported to CMS, 2019-2025
20 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.55 · 2021: $45.19 · 2022: $194 · 2023: $330 · 2024: $131 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $229.58 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $83.38 | 2021-2023 | |
| Amgen INC. | $83.13 | 2022-2025 | Evenity, Prolia, Prolia |
| Sumitomo Pharma America, INC. | $75.62 | 2024-2025 | Myfembree |
| Pfizer INC. | $50.61 | 2024-2025 | |
| Mylan Pharmaceuticals INC. | $39.61 | 2022 | |
| Abbvie INC. | $39.00 | 2022-2023 | |
| Shield Therapeutics INC | $35.38 | 2023-2024 | Accrufer |
| Coopersurgical, INC. | $35.24 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $34.27 | 2025 | Cologuard Collection Kit |
| Meditrina | $34.21 | 2022 | |
| Novo Nordisk INC | $33.41 | 2023 | Wegovy |
| Organon LLC | $33.15 | 2021-2025 | Jada System |
| Mayne Pharma Commercial LLC | $32.62 | 2025 | |
| Biogen, INC. | $27.34 | 2025 | Zurzuvae |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $24.72 | 2024 | Aptima |
| Genmab U.S., INC. | $22.37 | 2023 | Tivdak |
| Dexcom, INC. | $19.46 | 2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $18.55 | 2020 | |
| Daiichi Sankyo INC. | $18.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Pieczonka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.